hfpef semaglutide Poll: Do you think we'll see new FDA approval for semaglutide, specifically or Heart Failure and/or CKD, in 2025? 💊 This post highlights primary takeaways from 2 major trials from the past ~ STEP HFpEF DM: a sweet

Rare Variants in PPARG With Decreased Activity in Adipocyte Differentiation are Associated With Increased Risk of Type 2 Diabetes

This is often: A BMI of 30 or above for obesity A BMI of 27 or above for overweight if there is at least one weight-related health condition Weight-related conditions can include high blood pressure, raised cholesterol, prediabetes, type 2 diabetes or sleep apnoea

Patient Success Stories Many patients have experienced transformative results with Semaglutide, reporting better control over their diabetes and significant weight loss achievements

HUBERMAN: This is the consequence of sunlight activating the melanocorticoid system